Research and Markets: Staphylococcus Aureus Infections - Pipeline Review, H1 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/j5lv6n/staphylococcus) has announced the addition of the "Staphylococcus Aureus Infections - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Staphylococcus Aureus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Staphylococcus Aureus Infections and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Mentioned

Partial list of the 90+ companies featured in this comprehensive report:

  • Absynth Biologics
  • Bharat Biotech International
  • BioDiem
  • Cellceutix
  • Daiichi Sankyo
  • Debiopharm International
  • Ensoltek
  • Excelimmune
  • F. Hoffmann-La Roche
  • Galapagos
  • Helix BioMedix
  • Humabs BioMed
  • Ildong Pharmaceutical
  • Imaxio
  • Kyorin Pharmaceutical
  • Lascco
  • LegoChem Biosciences
  • Madam Therapeutics
  • Melinta Therapeutics
  • Merck & Co.
  • Nabriva Therapeutics
  • NanoBio
  • Omnia Molecular
  • Oragenics
  • Pepscan Presto
  • Pfizer
  • PharmaIN
  • Redx Pharma
  • Sarepta Therapeutics
  • Savara
  • Taejoon Pharm
  • United Therapeutics
  • Wintermute Biomedical
  • XBiotech USA
  • Yungjin Pharm

For more information, including full list of companies mentioned, please visit http://www.researchandmarkets.com/research/j5lv6n/staphylococcus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases